Metoprolol manufacturers?

See the DrugPatentWatch profile for Metoprolol

What companies are producing Metoprolol?

Several pharmaceutical companies are licensed to manufacture and market Metoprolol, a popular beta blocker used to treat high blood pressure, chest pain, and other heart conditions. [1]

AstraZeneca: The originator brand

AstraZeneca's subsidiary, AstraZeneca LP, acquired rights to Metoprolol through the 1999 purchase of the US unit of Zeneca. As the originator brand, AstraZeneca's Lopressor (Metoprolol succinate) is still widely prescribed in the US. [2]

Generic and biosimilar manufacturers

Multiple generic and biosimilar manufacturers have entered the market, offering their versions of Metoprolol. This competition has led to increased availability and affordability of the medication. [3]

* Teva Pharmaceuticals
* Mylan
* Sandoz (Novartis)
* Sun Pharmaceutical
* Watson Pharmaceuticals (currently a part of Teva Pharmaceutics)

Key patent information

According to DrugPatentWatch.com, the patent for Metoprolol succinate (Lopressor) expired in 2010, allowing generic manufacturers to enter the market. [4] However, other variations of Metoprolol, such as metoprolol tartrate, may still have active patents.

Regional variations

Availability and formulations of Metoprolol may vary across regions, influenced by local regulatory environments and patent landscapes. As a result, different manufacturers may hold licenses for specific versions of the medication in certain countries.

References:

[1] National Library of Medicine (nlm.nih.gov): Metoprolol
[2] AstraZeneca LP: Lopressor (metoprolol succinate) [prescribing information]
[3] IQVIA: Generics and Biosimilars Market Research
[4] DrugPatentWatch.com: Metoprolol Succinate Patent Expiration Dates